Dr Karthik Subramanian
Scientist
Rajiv Gandhi Centre for Biotechnology
Kerala
Expertise:
Infectious Diseases
14
Publications
3
Projects
447
Scopus Citations
437
CrossRef
12 Years 2 Months Total Experience
Scopus
447
Citations
8
h-index
CrossRef
437
Citations
8
h-index
Google Scholar
Loading Scholar statistics...
Professional Recognition
DBT-Ramalingaswami Re-entry fellowship
2021
Department of Biotechnology [DBT], India
DST-INSPIRE Faculty Research Grant
2020
Department of Science & Technology [DST], India
SERB-Start up Grant
2021
Department of Science & Technology [DST], India
Research article ranked Top downloaded article, Wiley Publications
2020
Wiley Publications
Research article recommended by Faculty of 1000 Prime
2019
Faculty of 1000 Prime
Travel grant
2019
Scandinavian Society for Immunology
Best Scientific paper of the year award
2018
Karolinska Institute, Stockholm
Research Foundation grant
2018
Karolinska Institute, Stockholm
Postdoctoral research fellowship
2014
Karolinska Institutet, Stockholm
Graduate Research scholarship
2009
Ministry of Education, Singapore
Best outgoing student of the batch
2009
SASTRA University, Tamilnadu, India
Dean's list award
2009
SASTRA University, Tamilnadu, India
Summer Research fellowship
2008
indian Academy of Sciences
Summer Research fellowship
2007
Indian Academy of Sciences
Community & Membership
No Data Found
There is currently nothing to display here.
Scandinavian Society for Immunology
MemberPersonal Details
Doctor of Philosophy
2013
N/A
Bachelor of Technology
2009
N/A
Scientist
Dec 2020 – Present
Rajiv Gandhi Centre for Biotechnology
Assistant Professor
Apr 2020 – Sep 2020
Karolinska Institute
Post-Doctoral Fellow
May 2014 – Mar 2020
Karolinska Institute
Medical and Health Sciences
Scholarly Work
Unravelling bacterial immunoevasion and host immune reprogramming strategies in invasive pneumococcal diseases
OtherInvestigating pneumococcal adaptation to intracellular survival within the host and characterization of macrophage extracellular vesicles for novel vaccine development
OtherDisarming bacterial pathogens using novel peptides that target pore-forming toxins: from in silico to in vivo
OtherNo Data Found
There is currently nothing to display here.
Mannose receptor-derived peptides for neutralizing pore-forming toxins for therapeutic uses.
Birgitta Henriques Normark
Karthik Subramanian
Georgios Sotiriou
-
Application No. :
PCT/EP2021/067923
Filed :
29-06-2021
Published :
30-11--0001
Filed
Scholarly Publications
Sorafenib, a clinical kinase inhibitor, attenuates Streptococcus pneumoniae pathogenesis and reduces disease progression in vivo
Open Access
Bacterial pore-forming toxin pneumolysin drives pathogenicity through host extracellular vesicles released during infection
Open AccessEditorial: Deceiving the host: mechanisms of immune evasion and survival by pneumococcal bacteria
Open AccessExtracellular vesicle-bound bacterial toxin pneumolysin triggers membrane engagement and damage beyond canonical pore formation
Emerging Roles of Extracellular Vesicles in Pneumococcal Infections: Immunomodulators to Potential Novel Vaccine Candidates.
Open AccessMannose receptor‐derived peptides neutralize pore‐forming toxins and reduce inflammation and development of pneumococcal disease
Open AccessEmerging concepts in the pathogenesis of the Streptococcus pneumoniae : From nasopharyngeal colonizer to intracellular pathogen
Open AccessGenomic Characterization of the Emerging Pathogen Streptococcus pseudopneumoniae.
Open Access
Showing 1 to 8 of 14 publications